 | • レポートコード：MRC2-11QY10809 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はトランスサイレチンのグローバル市場について調査・分析したレポートです。種類別（AG-10、ALN-TTRsc02、CRX-1008、EDE-1307、イノテルセンナトリウム、その他）市場規模、用途別（家族性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別トランスサイレチンの競争状況、市場シェア ・世界のトランスサイレチン市場：種類別市場規模 2015年-2020年（AG-10、ALN-TTRsc02、CRX-1008、EDE-1307、イノテルセンナトリウム、その他） ・世界のトランスサイレチン市場：種類別市場規模予測 2021年-2026年（AG-10、ALN-TTRsc02、CRX-1008、EDE-1307、イノテルセンナトリウム、その他） ・世界のトランスサイレチン市場：用途別市場規模 2015年-2020年（家族性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他） ・世界のトランスサイレチン市場：用途別市場規模予測 2021年-2026年（家族性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他） ・北米のトランスサイレチン市場分析：米国、カナダ ・ヨーロッパのトランスサイレチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのトランスサイレチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のトランスサイレチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのトランスサイレチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alnylam Pharmaceuticals Inc、Arcturus Therapeutics Inc、Ionis Pharmaceuticals Inc、Neurimmune Holding AG、Pfizer Inc、Prothena Corp Plc、Regeneron Pharmaceuticals Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Transthyretin Market
The global Transthyretin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Transthyretin Scope and Market Size
Transthyretin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transthyretin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Transthyretin market is segmented into
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
Segment by Application, the Transthyretin market is segmented into
Familial Amyloid Neuropathies
Alzheimer’s Disease
Cardomyopathy
Neuropathy
Others
Regional and Country-level Analysis
The Transthyretin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transthyretin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transthyretin Market Share Analysis
Transthyretin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transthyretin business, the date to enter into the Transthyretin market, Transthyretin product introduction, recent developments, etc.
The major vendors covered:
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
…
1 Study Coverage
1.1 Transthyretin Product Introduction
1.2 Market Segments
1.3 Key Transthyretin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transthyretin Market Size Growth Rate by Type
1.4.2 AG-10
1.4.3 ALN-TTRsc02
1.4.4 CRX-1008
1.4.5 EDE-1307
1.4.6 Inotersen Sodium
1.4.7 Others
1.5 Market by Application
1.5.1 Global Transthyretin Market Size Growth Rate by Application
1.5.2 Familial Amyloid Neuropathies
1.5.3 Alzheimer’s Disease
1.5.4 Cardomyopathy
1.5.5 Neuropathy
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Transthyretin Market Size, Estimates and Forecasts
2.1.1 Global Transthyretin Revenue 2015-2026
2.1.2 Global Transthyretin Sales 2015-2026
2.2 Global Transthyretin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Transthyretin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transthyretin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Transthyretin Competitor Landscape by Players
3.1 Transthyretin Sales by Manufacturers
3.1.1 Transthyretin Sales by Manufacturers (2015-2020)
3.1.2 Transthyretin Sales Market Share by Manufacturers (2015-2020)
3.2 Transthyretin Revenue by Manufacturers
3.2.1 Transthyretin Revenue by Manufacturers (2015-2020)
3.2.2 Transthyretin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transthyretin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transthyretin Revenue in 2019
3.2.5 Global Transthyretin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transthyretin Price by Manufacturers
3.4 Transthyretin Manufacturing Base Distribution, Product Types
3.4.1 Transthyretin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transthyretin Product Type
3.4.3 Date of International Manufacturers Enter into Transthyretin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Transthyretin Market Size by Type (2015-2020)
4.1.1 Global Transthyretin Sales by Type (2015-2020)
4.1.2 Global Transthyretin Revenue by Type (2015-2020)
4.1.3 Transthyretin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transthyretin Market Size Forecast by Type (2021-2026)
4.2.1 Global Transthyretin Sales Forecast by Type (2021-2026)
4.2.2 Global Transthyretin Revenue Forecast by Type (2021-2026)
4.2.3 Transthyretin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transthyretin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Transthyretin Market Size by Application (2015-2020)
5.1.1 Global Transthyretin Sales by Application (2015-2020)
5.1.2 Global Transthyretin Revenue by Application (2015-2020)
5.1.3 Transthyretin Price by Application (2015-2020)
5.2 Transthyretin Market Size Forecast by Application (2021-2026)
5.2.1 Global Transthyretin Sales Forecast by Application (2021-2026)
5.2.2 Global Transthyretin Revenue Forecast by Application (2021-2026)
5.2.3 Global Transthyretin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Transthyretin by Country
6.1.1 North America Transthyretin Sales by Country
6.1.2 North America Transthyretin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transthyretin Market Facts & Figures by Type
6.3 North America Transthyretin Market Facts & Figures by Application
7 Europe
7.1 Europe Transthyretin by Country
7.1.1 Europe Transthyretin Sales by Country
7.1.2 Europe Transthyretin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transthyretin Market Facts & Figures by Type
7.3 Europe Transthyretin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Transthyretin by Region
8.1.1 Asia Pacific Transthyretin Sales by Region
8.1.2 Asia Pacific Transthyretin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transthyretin Market Facts & Figures by Type
8.3 Asia Pacific Transthyretin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Transthyretin by Country
9.1.1 Latin America Transthyretin Sales by Country
9.1.2 Latin America Transthyretin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transthyretin Market Facts & Figures by Type
9.3 Central & South America Transthyretin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Transthyretin by Country
10.1.1 Middle East and Africa Transthyretin Sales by Country
10.1.2 Middle East and Africa Transthyretin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Transthyretin Market Facts & Figures by Type
10.3 Middle East and Africa Transthyretin Market Facts & Figures by Application
11 Company Profiles
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Corporation Information
11.1.2 Alnylam Pharmaceuticals Inc Description and Business Overview
11.1.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alnylam Pharmaceuticals Inc Transthyretin Products Offered
11.1.5 Alnylam Pharmaceuticals Inc Related Developments
11.2 Arcturus Therapeutics Inc
11.2.1 Arcturus Therapeutics Inc Corporation Information
11.2.2 Arcturus Therapeutics Inc Description and Business Overview
11.2.3 Arcturus Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Arcturus Therapeutics Inc Transthyretin Products Offered
11.2.5 Arcturus Therapeutics Inc Related Developments
11.3 Ionis Pharmaceuticals Inc
11.3.1 Ionis Pharmaceuticals Inc Corporation Information
11.3.2 Ionis Pharmaceuticals Inc Description and Business Overview
11.3.3 Ionis Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ionis Pharmaceuticals Inc Transthyretin Products Offered
11.3.5 Ionis Pharmaceuticals Inc Related Developments
11.4 Neurimmune Holding AG
11.4.1 Neurimmune Holding AG Corporation Information
11.4.2 Neurimmune Holding AG Description and Business Overview
11.4.3 Neurimmune Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Neurimmune Holding AG Transthyretin Products Offered
11.4.5 Neurimmune Holding AG Related Developments
11.5 Pfizer Inc
11.5.1 Pfizer Inc Corporation Information
11.5.2 Pfizer Inc Description and Business Overview
11.5.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Inc Transthyretin Products Offered
11.5.5 Pfizer Inc Related Developments
11.6 Prothena Corp Plc
11.6.1 Prothena Corp Plc Corporation Information
11.6.2 Prothena Corp Plc Description and Business Overview
11.6.3 Prothena Corp Plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Prothena Corp Plc Transthyretin Products Offered
11.6.5 Prothena Corp Plc Related Developments
11.7 Regeneron Pharmaceuticals Inc
11.7.1 Regeneron Pharmaceuticals Inc Corporation Information
11.7.2 Regeneron Pharmaceuticals Inc Description and Business Overview
11.7.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Regeneron Pharmaceuticals Inc Transthyretin Products Offered
11.7.5 Regeneron Pharmaceuticals Inc Related Developments
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Corporation Information
11.1.2 Alnylam Pharmaceuticals Inc Description and Business Overview
11.1.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alnylam Pharmaceuticals Inc Transthyretin Products Offered
11.1.5 Alnylam Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Transthyretin Market Estimates and Projections by Region
12.1.1 Global Transthyretin Sales Forecast by Regions 2021-2026
12.1.2 Global Transthyretin Revenue Forecast by Regions 2021-2026
12.2 North America Transthyretin Market Size Forecast (2021-2026)
12.2.1 North America: Transthyretin Sales Forecast (2021-2026)
12.2.2 North America: Transthyretin Revenue Forecast (2021-2026)
12.2.3 North America: Transthyretin Market Size Forecast by Country (2021-2026)
12.3 Europe Transthyretin Market Size Forecast (2021-2026)
12.3.1 Europe: Transthyretin Sales Forecast (2021-2026)
12.3.2 Europe: Transthyretin Revenue Forecast (2021-2026)
12.3.3 Europe: Transthyretin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transthyretin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transthyretin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transthyretin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transthyretin Market Size Forecast by Region (2021-2026)
12.5 Latin America Transthyretin Market Size Forecast (2021-2026)
12.5.1 Latin America: Transthyretin Sales Forecast (2021-2026)
12.5.2 Latin America: Transthyretin Revenue Forecast (2021-2026)
12.5.3 Latin America: Transthyretin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transthyretin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transthyretin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transthyretin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transthyretin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Transthyretin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transthyretin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Transthyretin Market Segments
Table 2. Ranking of Global Top Transthyretin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transthyretin Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AG-10
Table 5. Major Manufacturers of ALN-TTRsc02
Table 6. Major Manufacturers of CRX-1008
Table 7. Major Manufacturers of EDE-1307
Table 8. Major Manufacturers of Inotersen Sodium
Table 9. Major Manufacturers of Others
Table 10. Global Transthyretin Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Transthyretin Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Transthyretin Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Transthyretin Sales Market Share by Regions (2015-2020)
Table 14. Global Transthyretin Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Transthyretin Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Transthyretin Sales Share by Manufacturers (2015-2020)
Table 17. Global Transthyretin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Transthyretin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transthyretin as of 2019)
Table 19. Transthyretin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Transthyretin Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Transthyretin Price (2015-2020) (USD/Pcs)
Table 22. Transthyretin Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Transthyretin Product Type
Table 24. Date of International Manufacturers Enter into Transthyretin Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Transthyretin Sales by Type (2015-2020) (K Pcs)
Table 27. Global Transthyretin Sales Share by Type (2015-2020)
Table 28. Global Transthyretin Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Transthyretin Revenue Share by Type (2015-2020)
Table 30. Transthyretin Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Transthyretin Sales by Application (2015-2020) (K Pcs)
Table 32. Global Transthyretin Sales Share by Application (2015-2020)
Table 33. North America Transthyretin Sales by Country (2015-2020) (K Pcs)
Table 34. North America Transthyretin Sales Market Share by Country (2015-2020)
Table 35. North America Transthyretin Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Transthyretin Revenue Market Share by Country (2015-2020)
Table 37. North America Transthyretin Sales by Type (2015-2020) (K Pcs)
Table 38. North America Transthyretin Sales Market Share by Type (2015-2020)
Table 39. North America Transthyretin Sales by Application (2015-2020) (K Pcs)
Table 40. North America Transthyretin Sales Market Share by Application (2015-2020)
Table 41. Europe Transthyretin Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Transthyretin Sales Market Share by Country (2015-2020)
Table 43. Europe Transthyretin Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Transthyretin Revenue Market Share by Country (2015-2020)
Table 45. Europe Transthyretin Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Transthyretin Sales Market Share by Type (2015-2020)
Table 47. Europe Transthyretin Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Transthyretin Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Transthyretin Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Transthyretin Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Transthyretin Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Transthyretin Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Transthyretin Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Transthyretin Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Transthyretin Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Transthyretin Sales Market Share by Application (2015-2020)
Table 57. Latin America Transthyretin Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Transthyretin Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Transthyretin Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Transthyretin Revenue Market Share by Country (2015-2020)
Table 61. Latin America Transthyretin Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Transthyretin Sales Market Share by Type (2015-2020)
Table 63. Latin America Transthyretin Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Transthyretin Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Transthyretin Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Transthyretin Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Transthyretin Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Transthyretin Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Transthyretin Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Transthyretin Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Transthyretin Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Transthyretin Sales Market Share by Application (2015-2020)
Table 73. Alnylam Pharmaceuticals Inc Corporation Information
Table 74. Alnylam Pharmaceuticals Inc Description and Major Businesses
Table 75. Alnylam Pharmaceuticals Inc Transthyretin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Alnylam Pharmaceuticals Inc Product
Table 77. Alnylam Pharmaceuticals Inc Recent Development
Table 78. Arcturus Therapeutics Inc Corporation Information
Table 79. Arcturus Therapeutics Inc Description and Major Businesses
Table 80. Arcturus Therapeutics Inc Transthyretin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Arcturus Therapeutics Inc Product
Table 82. Arcturus Therapeutics Inc Recent Development
Table 83. Ionis Pharmaceuticals Inc Corporation Information
Table 84. Ionis Pharmaceuticals Inc Description and Major Businesses
Table 85. Ionis Pharmaceuticals Inc Transthyretin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Ionis Pharmaceuticals Inc Product
Table 87. Ionis Pharmaceuticals Inc Recent Development
Table 88. Neurimmune Holding AG Corporation Information
Table 89. Neurimmune Holding AG Description and Major Businesses
Table 90. Neurimmune Holding AG Transthyretin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Neurimmune Holding AG Product
Table 92. Neurimmune Holding AG Recent Development
Table 93. Pfizer Inc Corporation Information
Table 94. Pfizer Inc Description and Major Businesses
Table 95. Pfizer Inc Transthyretin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Pfizer Inc Product
Table 97. Pfizer Inc Recent Development
Table 98. Prothena Corp Plc Corporation Information
Table 99. Prothena Corp Plc Description and Major Businesses
Table 100. Prothena Corp Plc Transthyretin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Prothena Corp Plc Product
Table 102. Prothena Corp Plc Recent Development
Table 103. Regeneron Pharmaceuticals Inc Corporation Information
Table 104. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 105. Regeneron Pharmaceuticals Inc Transthyretin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Regeneron Pharmaceuticals Inc Product
Table 107. Regeneron Pharmaceuticals Inc Recent Development
Table 108. Global Transthyretin Sales Forecast by Regions (2021-2026) (K Pcs)
Table 109. Global Transthyretin Sales Market Share Forecast by Regions (2021-2026)
Table 110. Global Transthyretin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 111. Global Transthyretin Revenue Market Share Forecast by Regions (2021-2026)
Table 112. North America: Transthyretin Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. North America: Transthyretin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Europe: Transthyretin Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Europe: Transthyretin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Asia Pacific: Transthyretin Sales Forecast by Region (2021-2026) (K Pcs)
Table 117. Asia Pacific: Transthyretin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 118. Latin America: Transthyretin Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Latin America: Transthyretin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Middle East and Africa: Transthyretin Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. Middle East and Africa: Transthyretin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Main Points Interviewed from Key Transthyretin Players
Table 126. Transthyretin Customers List
Table 127. Transthyretin Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Transthyretin Product Picture
Figure 2. Global Transthyretin Sales Market Share by Type in 2020 & 2026
Figure 3. AG-10 Product Picture
Figure 4. ALN-TTRsc02 Product Picture
Figure 5. CRX-1008 Product Picture
Figure 6. EDE-1307 Product Picture
Figure 7. Inotersen Sodium Product Picture
Figure 8. Others Product Picture
Figure 9. Global Transthyretin Sales Market Share by Application in 2020 & 2026
Figure 10. Familial Amyloid Neuropathies
Figure 11. Alzheimer's Disease
Figure 12. Cardomyopathy
Figure 13. Neuropathy
Figure 14. Others
Figure 15. Transthyretin Report Years Considered
Figure 16. Global Transthyretin Market Size 2015-2026 (US$ Million)
Figure 17. Global Transthyretin Sales 2015-2026 (K Pcs)
Figure 18. Global Transthyretin Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Transthyretin Sales Market Share by Region (2015-2020)
Figure 20. Global Transthyretin Sales Market Share by Region in 2019
Figure 21. Global Transthyretin Revenue Market Share by Region (2015-2020)
Figure 22. Global Transthyretin Revenue Market Share by Region in 2019
Figure 23. Global Transthyretin Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Transthyretin Revenue in 2019
Figure 25. Transthyretin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Transthyretin Sales Market Share by Type (2015-2020)
Figure 27. Global Transthyretin Sales Market Share by Type in 2019
Figure 28. Global Transthyretin Revenue Market Share by Type (2015-2020)
Figure 29. Global Transthyretin Revenue Market Share by Type in 2019
Figure 30. Global Transthyretin Market Share by Price Range (2015-2020)
Figure 31. Global Transthyretin Sales Market Share by Application (2015-2020)
Figure 32. Global Transthyretin Sales Market Share by Application in 2019
Figure 33. Global Transthyretin Revenue Market Share by Application (2015-2020)
Figure 34. Global Transthyretin Revenue Market Share by Application in 2019
Figure 35. North America Transthyretin Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Transthyretin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Transthyretin Sales Market Share by Country in 2019
Figure 38. North America Transthyretin Revenue Market Share by Country in 2019
Figure 39. U.S. Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Transthyretin Market Share by Type in 2019
Figure 44. North America Transthyretin Market Share by Application in 2019
Figure 45. Europe Transthyretin Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Transthyretin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Transthyretin Sales Market Share by Country in 2019
Figure 48. Europe Transthyretin Revenue Market Share by Country in 2019
Figure 49. Germany Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Transthyretin Market Share by Type in 2019
Figure 60. Europe Transthyretin Market Share by Application in 2019
Figure 61. Asia Pacific Transthyretin Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Transthyretin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Transthyretin Sales Market Share by Region in 2019
Figure 64. Asia Pacific Transthyretin Revenue Market Share by Region in 2019
Figure 65. China Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Transthyretin Market Share by Type in 2019
Figure 88. Asia Pacific Transthyretin Market Share by Application in 2019
Figure 89. Latin America Transthyretin Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Transthyretin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Transthyretin Sales Market Share by Country in 2019
Figure 92. Latin America Transthyretin Revenue Market Share by Country in 2019
Figure 93. Mexico Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Transthyretin Market Share by Type in 2019
Figure 100. Latin America Transthyretin Market Share by Application in 2019
Figure 101. Middle East and Africa Transthyretin Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Transthyretin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Transthyretin Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Transthyretin Revenue Market Share by Country in 2019
Figure 105. Turkey Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Transthyretin Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Transthyretin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Transthyretin Market Share by Type in 2019
Figure 112. Middle East and Africa Transthyretin Market Share by Application in 2019
Figure 113. North America Transthyretin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Transthyretin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Transthyretin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Transthyretin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Transthyretin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Transthyretin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Transthyretin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Transthyretin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Transthyretin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Transthyretin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
トランスサイレチンアミロイドーシス（ATTR）の世界市場（～2026年） Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e. Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR. While Hereditary ATTR is caused by point m…- 家族性アミロイド多発神経障害（FAP）の世界市場（～2026年） Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the deposition of protein and/or amyloid fibrils around the peripheral nerves and in various tissues, including the heart muscle. Globally, development of new dru…
- アルツハイマー病の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer's Disease Scope and Market Size Alzheimer's Disease market is seg…
- 膵島アミロイドポリペプチドの世界市場（～2026年） Market Analysis and Insights: Global Islet Amyloid Polypeptide Market The global Islet Amyloid Polypeptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Islet Amyloid Polypeptide Scope and Market Size Islet Amyloid P…
- アルツハイマーの世界市場（～2026年） Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dement…